Xuejun Chen Selected Research

parsaclisib

11/2020	An Open-Label Study to Assess the Effect of Itraconazole and Rifampin on Parsaclisib Pharmacokinetics When Administered Orally in Healthy Participants.
1/2019	Parsaclisib, a potent and highly selective PI3Kδ inhibitor, in patients with relapsed or refractory B-cell malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xuejun Chen Research Topics

Disease

22	Infections 01/2022 - 11/2005
19	Neoplasms (Cancer) 01/2022 - 02/2012
5	Viremia 01/2022 - 01/2016
5	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2012
4	Cholangiocarcinoma 01/2022 - 10/2021
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2010
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 01/2020
3	Sepsis (Septicemia) 11/2019 - 07/2011
3	Primary Myelofibrosis (Myelosclerosis) 10/2018 - 12/2011
2	Rheumatoid Arthritis 01/2022 - 12/2014
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 01/2020
2	Pneumonia (Pneumonitis) 01/2022 - 07/2015
2	Acquired Immunodeficiency Syndrome (AIDS) 12/2021 - 10/2015
2	Squamous Cell Carcinoma of Head and Neck 09/2021 - 01/2010
2	Proteinuria 09/2021 - 02/2015
2	Nephrotic Syndrome (Syndrome, Nephrotic) 09/2021 - 02/2015
2	Head and Neck Neoplasms (Head and Neck Cancer) 09/2021 - 04/2014
2	Body Weight (Weight, Body) 03/2021 - 07/2013
2	Hemorrhage 01/2021 - 09/2012
2	Virus Diseases (Viral Diseases) 01/2020 - 06/2015
2	HIV Infections (HIV Infection) 01/2020 - 06/2015
2	Human Influenza (Influenza) 01/2019 - 07/2017
2	Neoplasm Metastasis (Metastasis) 04/2017 - 02/2012
2	Leukemia 10/2015 - 07/2011
2	Neutropenia 10/2015 - 07/2011
2	Polycythemia Vera 10/2015 - 07/2013
2	Ovarian Epithelial Carcinoma 01/2015 - 08/2014
2	Carcinoma (Carcinomatosis) 05/2013 - 01/2012
2	Bacterial Infections (Bacterial Infection) 07/2011 - 11/2005
2	Onychomycosis (Tinea Unguium) 11/2006 - 12/2004
1	Stress Fractures (Stress Fracture) 05/2022
1	Osteoarthritis 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Coronavirus Infections 01/2022
1	Inflammation (Inflammations) 12/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 09/2021
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 09/2021
1	Atopic Dermatitis (Atopic Eczema) 07/2021

Drug/Important Bio-Agent (IBA)

9	Broadly Neutralizing AntibodiesIBA 01/2022 - 10/2014
9	AntibodiesIBA 12/2021 - 10/2014
6	Proteins (Proteins, Gene)FDA Link 12/2021 - 04/2011
6	Janus KinasesIBA 07/2021 - 06/2012
6	ruxolitinibIBA 07/2021 - 12/2011
6	itacitinibIBA 01/2021 - 01/2018
5	VaccinesIBA 12/2021 - 07/2015
4	Messenger RNA (mRNA)IBA 12/2021 - 04/2011
4	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2021 - 01/2018
4	Monoclonal AntibodiesIBA 01/2021 - 01/2016
4	Janus Kinase 1IBA 01/2020 - 07/2013
4	Glycoproteins (Glycoprotein)IBA 09/2019 - 07/2014
4	EnzymesIBA 01/2017 - 01/2010
4	Aquaporin 5IBA 12/2015 - 01/2012
3	Pharmaceutical PreparationsIBA 01/2022 - 02/2012
3	EpitopesIBA 01/2022 - 01/2018
3	pemigatinibIBA 01/2022 - 01/2022
3	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022 - 10/2021
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2016
3	Cisplatin (Platino)FDA LinkGeneric 12/2015 - 01/2012
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 02/2012
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 12/2019
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2020 - 01/2010
2	parsaclisibIBA 11/2020 - 01/2019
2	Hemagglutinins (Hemagglutinin)IBA 01/2019 - 07/2017
2	Alanine Transaminase (SGPT)IBA 01/2019 - 04/2015
2	INCB039110IBA 01/2018 - 08/2016
2	Neutralizing AntibodiesIBA 01/2017 - 06/2015
2	Antiviral Agents (Antivirals)IBA 01/2017 - 01/2016
2	Aquaporins (Water Channels)IBA 12/2015 - 08/2014
2	Biological ProductsIBA 07/2014 - 04/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2011 - 11/2005
1	MetalsIBA 05/2022
1	GelatinIBA 05/2022
1	LigandsIBA 05/2022
1	gelatin filmIBA 05/2022
1	Meloxicam (Mobic)FDA LinkGeneric 01/2022
1	Penicillins (Penicillin)FDA Link 01/2022
1	tyrosine receptor (receptor, tyrosine)IBA 01/2022
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2022
1	Tissue Inhibitor of MetalloproteinasesIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2022
1	HMGB1 Protein (HMG1)IBA 12/2021
1	mRNA VaccinesIBA 12/2021
1	Intravenous AnestheticsIBA 11/2021
1	Etomidate FDA LinkGeneric 11/2021
1	AutoantibodiesIBA 09/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 09/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2021
1	Annexin A2 (Annexin II)IBA 09/2021
1	Tyrosine Kinase InhibitorsIBA 09/2021
1	ErbB Receptors (EGF Receptor)IBA 09/2021

Therapy/Procedure

7	Therapeutics 01/2021 - 12/2004
5	Drug Therapy (Chemotherapy) 01/2022 - 09/2012
2	Aftercare (After-Treatment) 01/2022 - 01/2016
2	Neck Dissection (Radical Neck Dissection) 01/2020 - 01/2019
2	Laryngectomy 01/2019 - 01/2014
2	Gas Lasers 01/2019 - 01/2014
2	Highly Active Antiretroviral Therapy (HAART) 01/2016 - 10/2015